Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in Lithuania, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Lithuania data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €833.4k | €922.5k | €1m | |||
| Patients | 569 | 630 | 690 |
Forecasts to 2030 — sales, patients and the full Lithuania series — are in the Lithuania data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
From International Cannabis Weekly, our free global briefing.
№302 · 9 Jun 2023 · Regulation
lrt.lt · №280 · 6 Jan 2023 · Regulation
lrt.lt · №278 · 16 Dec 2022 · Regulation
lrt.lt · №254 · 1 Jul 2022 · Adult-use
lrt.lt · №248 · 20 May 2022 · Regulation
HempToday · №226 · 3 Dec 2021 · Hemp & CBD
On 11 October 2018, Lithuania legalised the manufacturing, import, export and distribution of medical cannabis. The law came into effect on 1 May 2019, however, the industry has been slow to be implemented, with no patients receiving medical cannabis.
Under the framework, patients suffering from cancer, multiple sclerosis, epilepsy and AIDS are technically able to receive medical cannabis treatment.
Additionally, companies can obtain licences for the manufacturing, wholesale, import & export and retail of medical cannabis products through the State Medicines Control Agency.
The cultivation of medical cannabis in Lithuania is not allowed.